GSK Surges 8% After Bumping Its 2031 Outlook To North Of $50 Billion
GSK delivered a mixed fourth-quarter report Wednesday, but GSK stock surged on its long-term outlook for more than $50 ...
KLA Stock Rising; Key Ratings Make It One To Watch
KLA products are an integral part of the chipmaking process. Taking a look at top and bottom line numbers, the company has ...